Phase 2 study of aldoxorubicin in relapsed glioblastoma

MLA

Shanta Chawla, et al. “Phase 2 Study of Aldoxorubicin in Relapsed Glioblastoma.” Journal of Clinical Oncology, vol. 34, May 2016, p. 2027. EBSCOhost, https://doi.org/10.1200/jco.2016.34.15_suppl.2027.

APA

Shanta Chawla, Hillary Dinh, Scott Wieland, Sant P. Chawla, Jana Portnow, Daniel J. Levitt, Morris D. Groves, & Brian C. Boulmay. (2016). Phase 2 study of aldoxorubicin in relapsed glioblastoma. Journal of Clinical Oncology, 34, 2027. https://doi.org/10.1200/jco.2016.34.15_suppl.2027

Chicago

Shanta Chawla, Hillary Dinh, Scott Wieland, Sant P. Chawla, Jana Portnow, Daniel J. Levitt, Morris D. Groves, and Brian C. Boulmay. 2016. “Phase 2 Study of Aldoxorubicin in Relapsed Glioblastoma.” Journal of Clinical Oncology 34 (May): 2027. doi:10.1200/jco.2016.34.15_suppl.2027.